Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland - A review of current recommendations

Head and Neck

Volumn 33, Issue 12, 2011, Pages 1789-1795

  O'Hara, James ^a   Ferlito, Alfio ^b   Takes, Robert P ^c   Rinaldo, Alessandra ^b   Strojan, Primož ^d   Shaha, Ashok R ^e   Rodrigo, Juan P ^f,g   Paleri, Vinidh ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF UDINE   (Italy)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INSTITUTE OF ONCOLOGY   (Slovenia)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

cutaneous squamous cell carcinoma; lymph node metastases; parotid gland; radiotherapy; surgery

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CUTANEOUS SQUAMOUS CELL CARCINOMA; DISEASE FREE SURVIVAL; ELECTRON THERAPY; FOLLOW UP; GRAFT RECIPIENT; HEAD AND NECK CARCINOMA; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; LYMPH NODE METASTASIS; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND; PAROTIDECTOMY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN COLOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; PAROTID NEOPLASMS; RISK FACTORS; SKIN NEOPLASMS;

EID: 81255161315     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21583     Document Type: Article

References (28)

1. Bron LP, Traynor SJ, McNeil EB, O'Brien CJ,. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope 2003; 113: 1070-1075. (Pubitemid 36676609)
2. Alam M, Ratner D,. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344: 975-983. (Pubitemid 32240317)
3. Veness MJ, Porceddu S, Palme CE, Morgan GJ,. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29: 621-631. (Pubitemid 47168232)
4. Ch'ng S, Maitra A, Lea R, Brasch H, Tan ST,. Parotid metastasis-an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg 2006; 59: 1288-1293. (Pubitemid 44734524)
5. Southwell KE, Chaplin JM, Eisenberg RL, McIvor NP, Morton RP,. Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck. Head Neck 2006; 28: 244-248. (Pubitemid 43269891)
6. Veness MJ, Harris D,. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Australas Radiol 2007; 51: 12-20. (Pubitemid 46087986)
7. Teymoortash A, Dünne AA, Werner JA,. Parotideal lymph node metastasis in squamous cell carcinoma of the skin. Eur J Dermatol 2002; 12: 376-380. (Pubitemid 34713109)
8. Veness MJ,. High-risk cutaneous squamous cell carcinoma of the head and neck. J Biomed Biotechnol 2007; 2007: 80572.
9. Moore BA, Weber RS, Prieto V, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005; 115: 1561-1567. (Pubitemid 41330662)
10. Ch'ng S, Low I, Ng D, et al. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Hum Pathol 2008; 39: 344-349. (Pubitemid 351200502)
11. Vauterin TJ, Veness MJ, Morgan GJ, Poulsen MG, O'Brien CJ,. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck 2006; 28: 785-791. (Pubitemid 44320530)
12. Hinerman RW, Indelicato DJ, Amdur RJ, et al. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope 2008; 118: 1989-1996.
13. O'Brien CJ,. The parotid gland as a metastatic basin for cutaneous cancer. Arch Otolaryngol Head Neck Surg 2005; 131: 551-555. (Pubitemid 41058040)
14. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a mulitcenter study of treatment outcomes. Cancer 2006; 106: 1078-1083.
15. Veness MJ, Morgan GJ, Palme CE, Gebski V,. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005; 115: 870-875. (Pubitemid 40604696)
16. Chen AM, Grekin RC, Garcia J, Bucci MK, Margolis LW,. Radiation therapy for cutaneous squamous cell carcinoma involving the parotid area lymph nodes: dose and volume considerations. Int J Radiat Oncol Biol Phys 2007; 69: 1377-1380. (Pubitemid 350116397)
17. Ebrahimi A, Moncrieff MD, Clark JR, et al. Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary. Head Neck 2010; 10: 1288-1294.
18. Ross AS, Schmults CD,. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg 2006; 32: 1309-1321. (Pubitemid 44691132)
19. Mendenhall WM, Amdur RJ, Hinerman RW, Cognetta AB, Mendenhall NP,. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope 2009; 119: 1994-1999.
20. Brown PD, Eshleman JS, Foote RL, Strome SE,. An analysis of facial nerve function in irradiated and unirradiated facial nerve grafts. Int J Radiat Oncol Biol Phys 2000; 48: 737-743.
21. Iyer NG, Clark JR, Murali R, Gao K, O'Brien CJ,. Outcomes following parotidectomy for metastatic squamous cell carcinoma with microscopic residual disease: implications for facial nerve preservation. Head Neck 2009; 31: 21-27.
22. Osborne RF, Shaw T, Zandifar H, Kraus D,. Elective parotidectomy in the management of advanced auricular malignancies. Laryngoscope 2008; 118: 2139-2145.
23. Ch'ng S, Maitra A, Allison R, et al. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol 2008; 98: 101-105.
24. Spencer S, Carroll W, Nabell L, et al. Phase II postoperative adjuvant radiotherapy and erlotinib in patients with stage III cutaneous squamous cell carcinoma. J Clin Oncol 2010: 28 (Suppl): e16007 (abstract).
25. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA,. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002; 24: 417-422. (Pubitemid 34506700)
26. Audet N, Palme CE, Gullane PJ, et al. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck 2004; 26: 727-732. (Pubitemid 39014638)
27. Forest VI, Clark JJ, Veness MJ, Milross C,. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer 2010; 116: 1298-1304.
28. Sobin LH, Gospodarowicz MK, Wittekind C,. TNM Classification of Malignant Tumours, 7th ed. New York: Wiley-Blackwell, 2009.